Pular para o conteúdo
Merck

ABCs of Neonatal Cardiac Anesthesia.

Artificial organs (2013-01-12)
Chris Chin
RESUMO

Congenital heart disease (CHD) is relatively common and there are treatment options for virtually every form of CHD. With good care, the majority of babies can survive to adulthood; however, CHD remains a significant cause of death in infancy and neonates are especially vulnerable. In order to manage these patients, a clear understanding of the underlying pathophysiology and the planned surgical procedure is important. However, attention to detail and meticulous care are equally important, and, in addition, there are several management strategies that may standardize practice and can improve outcome.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Sulfato de magnésio, anhydrous, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Sulfato de magnésio, ACS reagent, ≥98%
Sigma-Aldrich
Sulfato de magnésio, anhydrous, reagent grade, ≥97%
Sigma-Aldrich
Sulfato de magnésio, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Sulfato de magnésio, BioReagent, for molecular biology, suitable for plant cell culture, ≥99.0%
Sigma-Aldrich
Sulfato de magnésio, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Sulfato de magnésio, puriss. p.a., drying agent, anhydrous, ≥98.0% (KT), powder (very fine)
Sigma-Aldrich
Magnesium sulfate solution, for molecular biology, 1.00 M±0.04 M
Sigma-Aldrich
Sulfato de magnésio, BioUltra, ≥99.5% (KT)
Sigma-Aldrich
Magnesium sulfate solution, BioUltra, for molecular biology
Sigma-Aldrich
Sulfato de magnésio, puriss. p.a., ACS reagent, ≥99.0% (KT)
Sigma-Aldrich
Sulfato de magnésio, 99.5-100.5% (calc. to the dried substance), meets analytical specification of Ph. Eur., BP,USP, FCC
Sigma-Aldrich
Sulfato de magnésio, ≥99.99% trace metals basis
Sigma-Aldrich
Sulfato de magnésio, BioXtra, ≥99.0%